Baruch Erez
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Lung Cancer Treatments and Mutations, Hepatocellular Carcinoma Treatment and Prognosis, Cancer, Hypoxia, and Metabolism, RNA modifications and cancer
Most-Cited Works
- → Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression(2014)977 cited
- → KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling(2013)196 cited
- → CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma(2012)170 cited
- → Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma(2011)161 cited
- → Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice(2010)82 cited
- → Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis(2012)70 cited
- → Fibulin-2 Is a Driver of Malignant Progression in Lung Adenocarcinoma(2013)48 cited
- → Abstract 3632: Addition of the HIF-1α inhibitor PX-478 enhances the therapeutic efficacy of EGFR inhibitors in an orthotopic human lung adenocarcinoma model(2010)1 cited
- → Abstract 5146: The histone demethylase KDM2A is a new promoter of tumorigenesis, drug target and negative prognostic biomarker for non-small cell lung cancer(2014)1 cited
- → Data from CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma(2023)